Literature DB >> 24106414

Magnetic resonance venography and liver transplant complications.

Evgeny Strovski1, Dave Liu, Charles Scudamore, Stephen Ho, Eric Yoshida, Darren Klass.   

Abstract

Hepatic vein stenosis is a rare but serious complication following liver transplantation. Multiple modalities can be utilized to image the hepatic vasculature. Magnetic resonance venography (MRV) provides certain advantages over ultrasound, computed tomography angiography and digital subtraction venography. MRV utilizes the same imaging principles of magnetic resonance angiography in order to image the venous system. Blood pool contrast agents, specifically gadofosveset trisodium, allow for steady state imaging up to 1 h following injection, with improved visualisation of vital venous structures by utilising delayed steady state imaging. Additionally, the inherent physics properties of magnetic resonance imaging also provide excellent soft tissue detail and thus help define the extent of complications that often plague the post-liver transplant patient. This case report describes the use of gadofosveset trisodium in a patient with hepatic venous stenosis following liver transplantation. Initial venography failed to outline the stenoses and thus MRV using a blood pool contrast agent was utilised in order to delineate the anatomy and plan a therapeutic endovascular procedure.

Entities:  

Keywords:  Blood pool; Gadofosveset trisodium; Liver transplant; Magnetic resonance angiography; Magnetic resonance venography; Nephrogenic systemic fibrosis

Mesh:

Substances:

Year:  2013        PMID: 24106414      PMCID: PMC3785635          DOI: 10.3748/wjg.v19.i36.6110

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

1.  Lower extremity venography with iohexol: results and complications.

Authors:  A W Lensing; P Prandoni; H R Büller; D Casara; A Cogo; J W ten Cate
Journal:  Radiology       Date:  1990-11       Impact factor: 11.105

Review 2.  Initial imaging recommendations for Vasovist angiography.

Authors:  Mike Hartmann; Andrea J Wiethoff; Hans-Rainer Hentrich; Martin Rohrer
Journal:  Eur Radiol       Date:  2006-02       Impact factor: 5.315

3.  Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.

Authors:  Martin Rohrer; Hans Bauer; Jan Mintorovitch; Martin Requardt; Hanns-Joachim Weinmann
Journal:  Invest Radiol       Date:  2005-11       Impact factor: 6.016

Review 4.  Management of venous outflow complications after liver transplantation.

Authors:  Michael D Darcy
Journal:  Tech Vasc Interv Radiol       Date:  2007-09

5.  Thoracic and abdominal MRA with gadofosveset: influence of injection rate on vessel signal and image quality.

Authors:  Johanna C Nissen; Ulrike I Attenberger; Christian Fink; Olaf Dietrich; Martin Rohrer; Stefan O Schoenberg; Henrik J Michaely
Journal:  Eur Radiol       Date:  2009-03-13       Impact factor: 5.315

6.  Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST study.

Authors:  Nicolas Janus; Vincent Launay-Vacher; Svetlana Karie; Olivier Clement; Elena Ledneva; Camille Frances; Gabriel Choukroun; Gilbert Deray
Journal:  Eur J Radiol       Date:  2009-01-06       Impact factor: 3.528

Review 7.  Gadofosveset-enhanced magnetic resonance angiography.

Authors:  Mathias Goyen
Journal:  Vasc Health Risk Manag       Date:  2008
  7 in total
  2 in total

Review 1.  Vascular complications following liver transplantation: A literature review of advances in 2015.

Authors:  Tullio Piardi; Martin Lhuaire; Onorina Bruno; Riccardo Memeo; Patrick Pessaux; Reza Kianmanesh; Daniele Sommacale
Journal:  World J Hepatol       Date:  2016-01-08

Review 2.  Iatrogenic-related transplant injuries: the role of the interventional radiologist.

Authors:  Alexander Copelan; Daniel George; Baljendra Kapoor; Hahn Vu Nghiem; Jonathan M Lorenz; Brian Erly; Weiping Wang
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.